Optical methods

Handbook of Experimental Pharmacology

Volumn 185, Issue PART2, 2008, Pages 3-12

  Bremer, Christoph ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; FLUORESCENT DYE; NANOPARTICLE; OLIGONUCLEOTIDE; PEPTIDE HYDROLASE;

ANIMAL; DIAGNOSTIC IMAGING; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; REVIEW; SIGNAL PROCESSING;

ANIMALS; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; DIAGNOSTIC IMAGING; DNA; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT DYES; GENE EXPRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; NANOPARTICLES; OLIGONUCLEOTIDES; OPTICS; PEPTIDE HYDROLASES; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 52049111609     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-77496-9_1     Document Type: Article

References (29)

1. Aparicio T, Kermorgant S, Dessirier V, Lewin MJ, Lehy T (1999) Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis 20:1445-1451
2. Bremer C, Ntziachristos V, Weissleder R (2003) Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 13:231-243
3. Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R (2005) Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol 40:321-327
4. Bremer C, Tung CH, Bogdanov A Jr,Weissleder R (2002) Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 222:814-818
5. Bremer C, Tung CH, Weissleder R (2002) Molecular imaging of MMP expression and therapeutic MMP inhibition. Acad Radiol 9(Suppl 2):S314-S315
6. Bullok K, Piwnica-Worms D (2005) Synthesis and characterization of a small, membranepermeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem 48:5404-5407
7. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL,Weissleder R (2002) In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105:2766-2771
8. Dubertret B, Calame M, Libchaber AJ (2001) Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat Biotechnol 19:365-370
9. Edwards DR, Murphy G (1998) Cancer. Proteases-invasion and more. Nature 394:527-528
10. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA (2000) Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97:3884-3889
11. Folkman J (1999) Angiogenic zip code. Nat Biotechnol 17:749
12. Herszenyi L, Plebani M, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F (1999) The role of cysteine and serine proteases in colorectal carcinoma. Cancer 86:1135-1142
13. Jaffer FA, Tung CH,Wykrzykowska JJ, Ho NH, Houng AK, Reed GL,Weissleder R (2004) Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110:170-176
14. Jiang T, Olson ES, Nguyen QT, RoyM, Jennings PA, Tsien RY (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 101:17867-17872
15. Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R (2002) Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 13:554-560
16. Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH (2005) Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 25:226-233
17. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63:8122-8125
18. Koblinski JE, Ahram M, Sloane BF (2000) Unraveling the role of proteases in cancer. Clin Chim Acta 291:113-135
19. Law B, Weissleder R, Tung CH (2005) Mechanism-based fluorescent reporter for protein kinase A detection. Chembiochem 6:1361-1367
20. Messerli SM, Prabhakar S, Tang Y, Shah K, Cortes ML, Murthy V, Weissleder R, Breakefield XO, Tung CH (2004) A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6:95-105
21. Metelev V,Weissleder R, Bogdanov A, Jr. (2004) Synthesis and properties of fluorescent NF-kappa B-recognizing hairpin oligodeoxyribonucleotide decoys. Bioconjug Chem 15:1481-1487
22. Pham W, Choi Y, Weissleder R, Tung CH (2004) Developing a peptide-based near-infrared molecular probe for protease sensing. Bioconjug Chem 15:1403-1407
23. Pham W, Weissleder R, Tung CH (2002) An azulene dimer as a near-infrared quencher. Angew Chem Int Ed Engl 41:3659-3662, 3519
24. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L (2004) Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15:1062-1067
25. Tung CH, Mahmood U, Bredow S, Weissleder R (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60:4953-4958
26. Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R (2004) In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 64:1579-1583
27. Tyagi S, Marras SA, Kramer FR (2000) Wavelength-shifting molecular beacons. Nat Biotechnol 18:1191-1196
28. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375-378
29. Wunder A, Tung CH, Muller-Ladner U,Weissleder R, Mahmood U (2004) In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 50:2459-2465